Sygnis SA (WSE:SYG)
Poland
· Delayed Price · Currency is PLN 1.300
-0.110 (-7.80%)
At close: Jun 27, 2025, 4:50 PM CET
Sygnis Revenue
Sygnis had revenue of 703.38K PLN in the quarter ending March 31, 2025, a decrease of -92.14%. This brings the company's revenue in the last twelve months to 15.41M, down -8.19% year-over-year. In the year 2023, Sygnis had annual revenue of 20.03M, down -29.73%.
Revenue (ttm)
15.41M
Revenue Growth
-8.19%
P/S Ratio
2.13
Revenue / Employee
856.22K
Employees
46
Market Cap
32.82M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 20.03M | -8.48M | -29.73% |
| Dec 31, 2022 | 28.51M | 25.11M | 739.70% |
| Dec 31, 2021 | 3.39M | 600.08K | 21.47% |
| Dec 31, 2020 | 2.79M | 509.95K | 22.32% |
| Dec 31, 2019 | 2.28M | -236.14K | -9.37% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| NEUCA | 12.82B |
| Synektik Spólka Akcyjna | 592.94M |
| Voxel | 556.98M |
| Celon Pharma | 215.11M |
| Ryvu Therapeutics | 97.57M |
| Centrum Medyczne ENEL-MED | 762.83M |
| Selvita | 359.79M |
| EMC Instytut Medyczny | 836.81M |